NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

W hen BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...

The Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, has launched ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

"People are going to die because we're cutting short funding for this technology," Dr. Jerome Adams said in an interview with ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

President Trump’s laissez-faire approach is notable, given that the development of the Covid vaccine was seen as one of his ...

Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA vaccine research.